Search

everythinglearnresearchcommunity

for

Search:↓

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

SQSTM1 is linked to increased risk of alopecia areata.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

DHT may reduce inflammation caused by certain bacteria in skin cells.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Platelet-released growth factors can reduce inflammation in joint disease.

Researchers found key regions in the mouse hairless gene that control its activity in skin and brain cells, affecting hair follicle function.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.